ZA201407940B - Inhibitor of jak1 and jak2 - Google Patents
Inhibitor of jak1 and jak2Info
- Publication number
- ZA201407940B ZA201407940B ZA2014/07940A ZA201407940A ZA201407940B ZA 201407940 B ZA201407940 B ZA 201407940B ZA 2014/07940 A ZA2014/07940 A ZA 2014/07940A ZA 201407940 A ZA201407940 A ZA 201407940A ZA 201407940 B ZA201407940 B ZA 201407940B
- Authority
- ZA
- South Africa
- Prior art keywords
- jak1
- jak2
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659679P | 2012-06-14 | 2012-06-14 | |
| PCT/US2013/044211 WO2013188184A1 (en) | 2012-06-14 | 2013-06-05 | Inhibitor of jak1 and jak2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201407940B true ZA201407940B (en) | 2016-05-25 |
Family
ID=48626679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/07940A ZA201407940B (en) | 2012-06-14 | 2014-10-30 | Inhibitor of jak1 and jak2 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9062050B2 (enExample) |
| EP (1) | EP2861231B1 (enExample) |
| JP (1) | JP6092376B2 (enExample) |
| KR (1) | KR20150008907A (enExample) |
| CN (1) | CN104349775B (enExample) |
| AU (1) | AU2013274641B2 (enExample) |
| BR (1) | BR112014030651A2 (enExample) |
| CA (1) | CA2871659C (enExample) |
| EA (1) | EA201492104A1 (enExample) |
| ES (1) | ES2605827T3 (enExample) |
| IN (1) | IN2014MN02228A (enExample) |
| MX (1) | MX2014015271A (enExample) |
| WO (1) | WO2013188184A1 (enExample) |
| ZA (1) | ZA201407940B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR105400A1 (es) * | 2015-08-04 | 2017-09-27 | Lilly Co Eli | Inhibidores de jak1 |
| AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| CN110229067A (zh) * | 2019-06-05 | 2019-09-13 | 南京焕然生物科技有限公司 | 一种2-氨基茚制备方法 |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| CN115141195B (zh) * | 2021-03-03 | 2024-02-06 | 成都先导药物开发股份有限公司 | 一种nuak抑制剂及其用途 |
| WO2023086320A1 (en) * | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
| CN116585312A (zh) * | 2023-04-30 | 2023-08-15 | 兰州大学第二医院 | 含苯氧基丙酸化合物的胰腺癌jak2和stat3双靶向抑制剂及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006087530A1 (en) | 2005-02-16 | 2006-08-24 | Astrazeneca Ab | Chemical compounds |
| TWI398252B (zh) * | 2006-05-26 | 2013-06-11 | Novartis Ag | 吡咯并嘧啶化合物及其用途 |
| US20100204246A1 (en) * | 2007-04-18 | 2010-08-12 | Astrazeneca Ab | 5-aminopyrazol-3-yl-3h-imidazo (4,5-b) pyridine derivatives and their use for the treatment of cancer |
-
2013
- 2013-06-05 AU AU2013274641A patent/AU2013274641B2/en not_active Ceased
- 2013-06-05 EA EA201492104A patent/EA201492104A1/ru unknown
- 2013-06-05 WO PCT/US2013/044211 patent/WO2013188184A1/en not_active Ceased
- 2013-06-05 KR KR20147034683A patent/KR20150008907A/ko not_active Abandoned
- 2013-06-05 EP EP13729215.7A patent/EP2861231B1/en not_active Not-in-force
- 2013-06-05 CA CA2871659A patent/CA2871659C/en not_active Expired - Fee Related
- 2013-06-05 BR BR112014030651A patent/BR112014030651A2/pt not_active IP Right Cessation
- 2013-06-05 CN CN201380031385.1A patent/CN104349775B/zh not_active Expired - Fee Related
- 2013-06-05 ES ES13729215.7T patent/ES2605827T3/es active Active
- 2013-06-05 JP JP2015517311A patent/JP6092376B2/ja not_active Expired - Fee Related
- 2013-06-05 MX MX2014015271A patent/MX2014015271A/es unknown
- 2013-06-05 IN IN2228MUN2014 patent/IN2014MN02228A/en unknown
- 2013-06-05 US US14/402,146 patent/US9062050B2/en not_active Expired - Fee Related
-
2014
- 2014-10-30 ZA ZA2014/07940A patent/ZA201407940B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013274641A1 (en) | 2014-11-20 |
| US9062050B2 (en) | 2015-06-23 |
| KR20150008907A (ko) | 2015-01-23 |
| CA2871659C (en) | 2017-04-04 |
| MX2014015271A (es) | 2015-03-05 |
| BR112014030651A2 (pt) | 2017-06-27 |
| CA2871659A1 (en) | 2013-12-19 |
| EA201492104A1 (ru) | 2015-06-30 |
| CN104349775A (zh) | 2015-02-11 |
| AU2013274641B2 (en) | 2015-09-24 |
| EP2861231A1 (en) | 2015-04-22 |
| WO2013188184A1 (en) | 2013-12-19 |
| ES2605827T3 (es) | 2017-03-16 |
| EP2861231B1 (en) | 2016-08-31 |
| JP2015519396A (ja) | 2015-07-09 |
| JP6092376B2 (ja) | 2017-03-08 |
| US20150133490A1 (en) | 2015-05-14 |
| CN104349775B (zh) | 2017-06-06 |
| IN2014MN02228A (enExample) | 2015-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP4029A (en) | Inhibitors of beta-secretase | |
| SG10201609940RA (en) | Compounds and their methods of use | |
| IL237849B (en) | ret suppressors and their uses | |
| EP2678018A4 (en) | COMBINATION OF CHINESE HEMMER AND USES THEREOF | |
| EP2776837A4 (en) | COMBINATION OF KINASEINHIBITORS AND THEIR USE | |
| PL2920149T3 (pl) | Związki 3-aminocykloalkilowe jako inhibitory ror-gamma-t oraz ich zastosowania | |
| SMT201900136T1 (it) | Inibitori di gsk3 e loro metodi di uso | |
| ZA201407940B (en) | Inhibitor of jak1 and jak2 | |
| EP2885314A4 (en) | FLUORINATED EPOXYCETONE COMPOUNDS AND USES THEREOF AS PROTEASE INHIBITORS | |
| IL236963A0 (en) | beta-secretase inhibitors | |
| IL237626A0 (en) | Novel inhibitory compounds of type a10 phosphodiesterase | |
| PL2888228T3 (pl) | Inhibitory oddziaływania CD40-TRAF6 | |
| IL238406A0 (en) | Mixed inhibitors of aminopeptidase n and nephrilysin | |
| IL238739A0 (en) | Novel phosphodiesterase type 10a inhibitory compounds | |
| ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
| EP2784068A4 (en) | PHOSPHODIESTERASE-4 INHIBITOR CAPABLE OF AVOIDING VOMITING | |
| IL236946A0 (en) | A10-type phosphodiesterase inhibitory compounds | |
| GB201209458D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201206048D0 (en) | Novel compounds and their use as kinase inhibitors |